142 related articles for article (PubMed ID: 21157331)
1. Noncirrhotic portal hypertension in HIV infection.
Vispo E; Morello J; Rodriguez-Novoa S; Soriano V
Curr Opin Infect Dis; 2011 Feb; 24(1):12-8. PubMed ID: 21157331
[TBL] [Abstract][Full Text] [Related]
2. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
Kovari H; Ledergerber B; Peter U; Flepp M; Jost J; Schmid P; Calmy A; Mueller NJ; Muellhaupt B; Weber R;
Clin Infect Dis; 2009 Aug; 49(4):626-35. PubMed ID: 19589079
[TBL] [Abstract][Full Text] [Related]
3. Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature.
Cesari M; Schiavini M; Marchetti G; Caramma I; Ortu M; Franzetti F; Galli M; Antinori S; Milazzo L
AIDS Patient Care STDS; 2010 Nov; 24(11):697-703. PubMed ID: 20969464
[TBL] [Abstract][Full Text] [Related]
4. Non-cirrhotic portal hypertension in HIV-infected individuals.
Scourfield A; Waters L; Holmes P; Panos G; Randell P; Jackson A; Mandalia S; Gazzard B; Nelson M
Int J STD AIDS; 2011 Jun; 22(6):324-8. PubMed ID: 21680667
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.
Maida I; Garcia-Gasco P; Sotgiu G; Rios MJ; Vispo ME; Martin-Carbonero L; Barreiro P; Mura MS; Babudieri S; Albertos S; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):103-7. PubMed ID: 18389904
[TBL] [Abstract][Full Text] [Related]
6. [Non-cirrhotic portal hypertension due to didanosina. A rare case].
Gamero MT; Gallardo MS; Aguilar V; Bravo E; Guevara J; Mejia F
Rev Gastroenterol Peru; 2017; 37(1):87-90. PubMed ID: 28489843
[TBL] [Abstract][Full Text] [Related]
7. Influence of antiretroviral therapy on liver disease.
Kovari H; Weber R
Curr Opin HIV AIDS; 2011 Jul; 6(4):272-7. PubMed ID: 21508839
[TBL] [Abstract][Full Text] [Related]
8. Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings.
Vispo E; Moreno A; Maida I; Barreiro P; Cuevas A; Albertos S; Soriano V
AIDS; 2010 May; 24(8):1171-6. PubMed ID: 20299955
[TBL] [Abstract][Full Text] [Related]
9. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.
Saifee S; Joelson D; Braude J; Shrestha R; Johnson M; Sellers M; Galambos MR; Rubin RA
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1167-9. PubMed ID: 18639498
[TBL] [Abstract][Full Text] [Related]
10. Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.
Chang HM; Tsai HC; Lee SS; Wann SR; Chen YS
Jpn J Infect Dis; 2012; 65(1):61-5. PubMed ID: 22274160
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.
Chang PE; Miquel R; Blanco JL; Laguno M; Bruguera M; Abraldes JG; Bosch J; Garcia-Pagan JC
Am J Gastroenterol; 2009 Jul; 104(7):1707-14. PubMed ID: 19471257
[TBL] [Abstract][Full Text] [Related]
12. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.
Schiano TD; Kotler DP; Ferran E; Fiel MI
Am J Gastroenterol; 2007 Nov; 102(11):2536-40. PubMed ID: 17640321
[TBL] [Abstract][Full Text] [Related]
13. Splenomegaly and variceal bleeding in a ten-year-old HIV-infected girl with noncirrhotic portal hypertension.
Giacomet V; Viganò A; Penagini F; Manfredini V; Maconi G; Camozzi M; Zuccotti GV
Pediatr Infect Dis J; 2012 Oct; 31(10):1059-60. PubMed ID: 22828640
[TBL] [Abstract][Full Text] [Related]
14. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.
Mendizabal M; Craviotto S; Chen T; Silva MO; Reddy KR
Ann Hepatol; 2009; 8(4):390-5. PubMed ID: 20009143
[TBL] [Abstract][Full Text] [Related]
15. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.
Schouten JN; Van der Ende ME; Koëter T; Rossing HH; Komuta M; Verheij J; van der Valk M; Hansen BE; Janssen HL
Aliment Pharmacol Ther; 2012 Nov; 36(9):875-85. PubMed ID: 22971050
[TBL] [Abstract][Full Text] [Related]
17. The burden of liver disease in human immunodeficiency virus-infected patients.
Puoti M; Moioli MC; Travi G; Rossotti R
Semin Liver Dis; 2012 May; 32(2):103-13. PubMed ID: 22760649
[TBL] [Abstract][Full Text] [Related]
18. [Portal hypertension and HIV infection].
Spahr L; Bihl F; Rubbia-Brandt L; Hadengue A
Rev Med Suisse; 2009 Sep; 5(215):1696-8, 1700. PubMed ID: 19803220
[TBL] [Abstract][Full Text] [Related]
19. Cryptogenic liver disease in HIV-seropositive men.
Dinh MH; Stosor V; Rao SM; Miller FH; Green RM
HIV Med; 2009 Aug; 10(7):447-53. PubMed ID: 19459992
[TBL] [Abstract][Full Text] [Related]
20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
